In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches-Reference-Cited by-同舟云学术

In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches

Published:2020 Issue: Volume: Page:189-228
ISSN:0065-230X
Container-title:Advances in Cancer Research
language:
Short-container-title:

Author:

Simond Alexandra M.,Muller William J.

Publisher

Elsevier

Reference186 articles.

1. Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice;Aggarwal;Clinical Cancer Research,2005

2. LKB1-dependent signaling pathways;Alessi;Annual Review of Biochemistry,2006

3. Endocrine-responsive breast cancer and strategies for combating resistance;Ali;Nature Reviews. Cancer,2002

4. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis;Andrechek;Proceedings of the National Academy of Sciences of the United States of America,2000

5. Gene expression profiling of Neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers;Andrechek;Cancer Research,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical Expression Levels of Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Ki-67 in Canine Cutaneous Squamous Cell Carcinomas;Current Issues in Molecular Biology;2024-05-19

2. Insulin receptor loss impairs mammary tumorigenesis in mice;Cell Reports;2023-11

3. HER2 overexpression initiates breast tumorigenesis non-cell-autonomously by inducing oxidative stress in the tissue microenvironment;2023-08-27

4. A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer;Journal of Drug Delivery Science and Technology;2023-01

5. Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer;Oncogene;2022-05-10